Vor Bio

Biotechnology Research • Cambridge, Massachusetts 02140, United States • 51-100 Employees

Company overview

Headquarters	Cambridge, Massachusetts 02140, United States
Phone number	+16176556580
Websites	vorbio.com vorbiopharma.com
NAICS	541714
SIC	283
Employees	51-100
Socials

Key Contacts at Vor Bio

Bo Cumbo

Board Of Directors

Renaldo Francois

Director, Quality Systems And Validation

Michel Detheux

Member Board Of Directors

Nolan Hsu

Director, Csv

Jianxin Hu

Senior Director, Head Of Process And Analytical Development

Patrick O'Hern

Director, Strategic Alliances

Karan Mehra

Senior Director, Strategy & Ops

Guangwu Guo

Associate Director, Quantitative Biology

Christina Kyriakopoulou

Associate Director, Supply Chain

Peter Parpos

Executive Director, Corporate Development

Vor Bio Email Formats

Vor Bio uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@vorbio.com), used 94.3% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@vorbio.com	94.3%
{first initial}{last name}	jdoe@vorbio.com	5.7%

About Vor Bio

Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and commercialization to address serious autoantibody-driven conditions worldwide.

Vor Bio revenue & valuation

Annual revenue	$37,500,000
Revenue per employee	$399,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$120,000,000
Total funding	No funding